Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avalon GloboCare (ALBT) Shares Outstanding (Diluted Average) (2021 - 2025)

Historic Shares Outstanding (Diluted Average) for Avalon GloboCare (ALBT) over the last 5 years, with Q3 2025 value amounting to $4.1 million.

  • Avalon GloboCare's Shares Outstanding (Diluted Average) rose 34019.52% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year increase of 34019.52%. This contributed to the annual value of $936614.0 for FY2024, which is 3343.37% up from last year.
  • As of Q3 2025, Avalon GloboCare's Shares Outstanding (Diluted Average) stood at $4.1 million, which was up 34019.52% from $2.2 million recorded in Q2 2025.
  • In the past 5 years, Avalon GloboCare's Shares Outstanding (Diluted Average) registered a high of $85.4 million during Q3 2021, and its lowest value of $701932.0 during Q4 2023.
  • Its 5-year average for Shares Outstanding (Diluted Average) is $13.7 million, with a median of $6.3 million in 2021.
  • In the last 5 years, Avalon GloboCare's Shares Outstanding (Diluted Average) tumbled by 9270.16% in 2024 and then surged by 34019.52% in 2025.
  • Avalon GloboCare's Shares Outstanding (Diluted Average) (Quarter) stood at $8.5 million in 2021, then grew by 9.86% to $9.3 million in 2022, then tumbled by 92.48% to $701932.0 in 2023, then skyrocketed by 33.43% to $936614.0 in 2024, then soared by 334.47% to $4.1 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $4.1 million in Q3 2025, compared to $2.2 million in Q2 2025 and $1.6 million in Q1 2025.